Delivery Order HHSD200200824959I-HHSD2002008249590007
Award Date 9/30/15
Potential Completion Date 3/31/19
Potential Value $38M
Funding Federal Agency
Contracting Federal Agency
Ultimate Awardee
Not listed PSC Category
Set-Aside Type
No Set-Aside Used
Federal Contract Vehicle
- Not listed
Extent Competed
Not Competed
Major Defense Program
Not listed Pricing Type
Firm Fixed Price
Place of Performance
Cambridge, MA 02139, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Other Statutory Authority
National Interest Action
Not listed Research Type
Not listed Primary Consortia Member
Not listed Similar Awards
- The U.S. Department of Health and Human Services Office of the Assistant Secretary for Preparedness and Response awarded Emergent Product Development Gaithersburg Inc. a firm fixed price contract valued at $804.9 million on August 30, 2019, for the manufacture and delivery of ACAM2000, a live vaccinia smallpox vaccine. The contract, which extends through August 29, 2029, supports the federal government's medical countermeasures stockpiling and pandemic preparedness initiatives. Work will be...
- <p>This is a contract awarded by the Department of Health and Human Services (HHS) Centers for Disease Control and Prevention (CDC) to Emergent Biodefense Operations Lansing LLC, also known as Emergent Biodefense, for the maintenance of a smallpox license. The contract is a delivery order with a firm fixed price of $38,430,000.00 and a completion date of January 31, 2019. The place of performance is located in Cambridge, Massachusetts. The contract does not have a set-aside designation.</p>
- This is a definitive contract awarded by the Department of Health and Human Services (HHS) Office of the Assistant Secretary for Preparedness and Response to Emergent Biodefense Operations Lansing LLC, a for-profit manufacturer of medical countermeasures. The $1,174,464,339.10 firm fixed-price contract is for the production of BioThrax, the only FDA-licensed vaccine for the prevention of anthrax disease, which is a critical component of the U.S. government's strategic national stockpile. The...
- The Centers for Disease Control and Prevention (CDC) Pittsburgh awarded a firm fixed-price purchase order valued at $2,825.20 to Emergent Biodefense Operations Lansing LLC for BioThrax vaccine, with an ultimate completion date of April 15, 2026. The place of performance is Atlanta, Georgia. This purchase order represents a civilian healthcare procurement with no set-aside designation and follows the Firm Fixed Price pricing model, indicating a predetermined cost structure for the vaccine...
- The U.S. Department of the Army Acquisition Support Center Joint PEO Chemical and Biological Defense awarded Emergent Biodefense Operations Lansing LLC a $66.9 million firm fixed-price delivery order on January 4, 2026, for the procurement of BioThrax (Anthrax Vaccine Absorbed). The contract, which carries no set-aside designation, is scheduled for completion by September 30, 2029, with manufacturing and delivery operations based in Lansing, Michigan. This delivery order is issued under an...
- The Department of Health and Human Services Office of the Assistant Secretary for Preparedness and Response awarded a Firm Fixed Price Purchase Order contract to Emergent Biodefense Operations Lansing LLC for the WETVAX 2021 project. The contract has a potential value of $141,400.00 and a completion date of August 31, 2021. The contract does not have a set-aside designation. Emergent Biodefense Operations Lansing LLC is the prime contractor for this award, which is likely related to the agency's...
- This federal contract was awarded by the Department of Health and Human Services (HHS) Office of the Assistant Secretary for Preparedness and Response to Emergent Biodefense Operations Lansing LLC for WETVAX POTENCY TESTING. The contract has a potential value of $136,612.00 and is a Firm Fixed Price Purchase Order. The place of performance is Canton, MA 02021, USA. The contract does not have a set-aside designation. As the awardee, Emergent Biodefense Operations Lansing LLC is a for-profit...
- This is a $1,054,186.47 delivery order contract awarded by the Office of the Assistant Secretary for Preparedness and Response (ASPR), a civilian agency, to The Texas A&M University System for the Centers for Innovation in Advanced Development and Manufacturing program. The contract involves technology transfer and cGMP (current Good Manufacturing Practice) manufacture of an adenovirus type 5 (Ad5) vectored anthrax vaccine. No set-aside was used. The prime contractor, Texas A&M...
- <p>This is a firm fixed-price delivery order contract for $838,800.00 awarded by the Centers for Disease Control and Prevention (CDC) to Sanofi Pasteur Biologics, LLC, a foreign-owned for-profit organization, to provide smallpox diluent. The contract has an ultimate completion date of July 6, 2017 and was awarded on May 18, 2016. There is no set-aside designation mentioned for this contract.</p>
- <p>This is a $135,895.50 firm fixed price purchase order awarded by the Department of Health and Human Services Office of the Assistant Secretary for Preparedness and Response to Emergent Biodefense Operations Lansing LLC for the annual potency testing of the WETVAX (APSV) vials stored at the Strategic National Stockpile (SNS). The contract has an end date of August 31, 2022 and was awarded on May 12, 2022. No set-aside was used for this procurement.</p>